These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7043188)

  • 1. Human factor B.
    Kerr MA
    Methods Enzymol; 1981; 80 Pt C():102-12. PubMed ID: 7043188
    [No Abstract]   [Full Text] [Related]  

  • 2. Limulus clotting factor B.
    Nakamura T; Muta T; Oda T; Morita T; Iwanaga S
    Methods Enzymol; 1993; 223():346-51. PubMed ID: 8271962
    [No Abstract]   [Full Text] [Related]  

  • 3. Limulus proclotting enzyme.
    Muta T; Nakamura T; Hashimoto R; Morita T; Iwanaga S
    Methods Enzymol; 1993; 223():352-8. PubMed ID: 8271964
    [No Abstract]   [Full Text] [Related]  

  • 4. The alternative complement pathway in bovine serum: the isolation of a serum protein with factor B activity.
    Pang AS; Aston WP
    Immunochemistry; 1978 Aug; 15(8):529-34. PubMed ID: 83291
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.
    Daha MR; van Es LA
    Immunology; 1980 Dec; 41(4):849-55. PubMed ID: 6906329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping.
    Ngan BY; Minta JO
    Mol Immunol; 1981 Dec; 18(12):1035-47. PubMed ID: 7038446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bf-immunofixation on cellogel membranes (author's transl)].
    Martin W; Ziegler C
    Blut; 1981 Jan; 42(1):23-6. PubMed ID: 7011443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical characterization of human factor B of the alternate pathway of complement activation.
    Curman B; Sandberg-Trägårdh L; Peterson PA
    Biochemistry; 1977 Nov; 16(24):5368-75. PubMed ID: 411505
    [No Abstract]   [Full Text] [Related]  

  • 9. The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.
    Koch C
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):253-9. PubMed ID: 3646826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in serum properdin factor B phenotype following human orthoptic liver transplantation.
    Hauptmann G; Tongio MM; Klein J; Mayer S; Cinqualbre J; Jeanblanc B; Kieny R
    Immunobiology; 1980; 158(1-2):76-81. PubMed ID: 7009411
    [No Abstract]   [Full Text] [Related]  

  • 11. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.
    Hamuro J; Hadding U; Bitter-Suermann D
    J Immunol; 1978 Feb; 120(2):438-44. PubMed ID: 74389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hemolytically inactive gene product of factor B.
    Mauff G; Federmann G; Hauptmann G
    Immunobiology; 1980; 158(1-2):96-100. PubMed ID: 6782013
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymerization of factor B of the alternative complement pathway via disulfide bond(s) in the presence of Cu2+ and stimulation by C3b, the major fragment of C3.
    Matsushita M; Iwasaki A; Okada H
    Biochem Biophys Res Commun; 1989 Nov; 165(1):101-5. PubMed ID: 2590211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a new BF F subtype variant by isoelectric focusing.
    Geserick G; Rose M; Martin W; Schröder H
    Exp Clin Immunogenet; 1989; 6(2):156-61. PubMed ID: 2629891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cells.
    Woo P; Lachmann PJ
    Immunology; 1981 Nov; 44(3):629-39. PubMed ID: 6976310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous inhibitors of factor B.
    Moriyama T; Kawamoto Y; Ichikawa H; Okamoto K; Inoue T; Kobayashi T; Miyama A
    Microbiol Immunol; 1983; 27(12):1079-91. PubMed ID: 6374390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.
    Schwaeble W; Lüttig B; Sokolowski T; Estaller C; Weiss EH; Meyer zum Büschenfelde KH; Whaley K; Dippold W
    Immunobiology; 1993 Jul; 188(3):221-32. PubMed ID: 8225386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis of factor B by plasma kallikrein and plasmin.
    Ikari N; Niinobe M; Fujii S
    FEBS Lett; 1981 Aug; 131(1):143-6. PubMed ID: 6456937
    [No Abstract]   [Full Text] [Related]  

  • 19. Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb.
    Niemann MA; Volanakis JE; Mole JE
    Biochemistry; 1980 Apr; 19(8):1576-83. PubMed ID: 6769474
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure and activation of complement components C2 and factor B.
    Gagnon J
    Philos Trans R Soc Lond B Biol Sci; 1984 Sep; 306(1129):301-9. PubMed ID: 6149575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.